Barclays PLC Ionis Pharmaceuticals Inc Call Options Transaction History

Barclays PLC

$357 Billion
Q4 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $3.1 Million - $4.05 Million	-85,000 Reduced 62.96%	50,000 $2.38 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $3.36 Million - $4.28 Million	80,000 Added 145.45%	135,000 $5.85 Million
Q4 2023 Feb 15, 2024	SELL	$43.39 - $51.63 $216,950 - $258,150	-5,000 Reduced 8.33%	55,000 $2.78 Million
Q3 2023 Nov 07, 2023	BUY	$38.5 - $47.13 $2.31 Million - $2.83 Million	60,000 New	60,000 $2.72 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $90,155 - $119,605	-1,900 Reduced 4.34%	41,900 $1.99 Million
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $421,650 - $549,450	-9,000 Reduced 17.05%	43,800 $2.58 Million
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $798,720 - $1.22 Million	-19,200 Reduced 26.67%	52,800 $2.5 Million
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $791,595 - $959,468	14,700 Added 25.65%	72,000 $4.35 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $230,334 - $281,385	-3,900 Reduced 6.37%	57,300 $3.43 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $925,141 - $1.28 Million	-14,900 Reduced 19.58%	61,200 $3.93 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $2.95 Million - $4.52 Million	-55,700 Reduced 42.26%	76,100 $6.18 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $767,649 - $1.05 Million	-17,700 Reduced 11.84%	131,800 $7.13 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1.11 Million - $1.39 Million	25,900 Added 20.95%	149,500 $7.71 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $243,180 - $304,200	6,000 Added 5.1%	123,600 $5.15 Million
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $5.13 Million - $6.4 Million	-116,300 Reduced 49.72%	117,600 $5.18 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $2.21 Million - $2.83 Million	43,900 Added 23.11%	233,900 $11.8 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $8.66 Million - $11.3 Million	190,000	190,000 $9.63 Million

Others Institutions Holding IONS

# of Institutions

416

Shares Held

140M

Call Options Held

861K

Put Options Held

714K

Vanguard Group Inc Valley Forge, PA

16.5M
Shares

$511 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$440 Million
0.31% of portfolio
Capital World Investors Los Angeles, CA

11.5M
Shares

$356 Million
0.06% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$320 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.67M
Shares

$269 Million
0.06% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account